GT BIOPHARMA, INC. Other Commitment, to be Paid, Year Three
GT BIOPHARMA, INC. (GTBP) had Other Commitment, to be Paid, Year Three of $1.01 million as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Notes › Commitment and Contingencies › Other Commitment, Fiscal Year Maturity › Other Commitment, to be Paid, Year Two and Three
us-gaap:OtherCommitmentDueInThirdYear · last filed 2022-03-28
- 2021-12-31: Other Commitment, to be Paid, Year Three $1.01M.
| Period end | Other Commitment, to be Paid, Year Three |
|---|---|
| 2021-12-31 | $1.01M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |